International pharmaceutical outsourcing services provider, PCI Pharma Services, welcomed an official visit by the UK government to its Philadelphia headquarters earlier this week.
UK-US institute
This official visit, led by secretary of state for Wales and UK board of trade advisor, Alun Cairns, formed part of a trade mission to attract US businesses to invest in Wales and to build on a commercial relationship already worth more than $46 billion (£33.5 billion).
“Wales and the US are close trading partners — and I want to ensure that we continue to build on this important relationship by creating more investment and exporting opportunities for companies from both countries,” said Cairns. “US firms invest more than £30 billion in the UK and our commercial relationship is stronger than ever. We want to see that partnership continue to grow and flourish, making Wales the place of choice for investors.”
“We were delighted to welcome the UK government delegation to our Philadelphia site. It was an exceptional opportunity to showcase our market-leading outsourced manufacturing, packaging and logistical services for the global healthcare industry,” added PCI Pharma Services president and CEO Bill Mitchell. “The visit pays great testimony to our US operations, but also our ongoing commitment to our EU operations. Our Welsh sites play a very important part in delivering on our strategy to be the partner of choice for pharmaceutical and biotech companies to bring lifesaving medicines to patients around the world. PCI Pharma Services is honoured to support clients with clinical and commercial scale drug manufacturing, packaging and labelling of clinical trial medicines; global logistics services to investigational sites; and commercial contract packaging services.”